Arrowhead Pharmaceuticals (ARWR) P/FCF US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| P/FCF | 43.8 | -18.4 | 0.00 | -3.84 | 29.4 | -175.5 | ||
| Changes by years, y/y, % | -209% | -142% | -100% | -866% | ||||
Arrowhead Pharmaceuticals. P/FCF
Arrowhead Pharmaceuticals. P/FCF, changes, %
Arrowhead Pharmaceuticals (ARWR) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| P/FCF | 177.1 | -124.7 | 29.8 | 28.9 | -175.5 | -175.5 | ||
| Changes by years, y/y, % | -863% | -803% | -199% | |||||
| Changes by quarters, q/q, % | -4 412% | -170% | -124% | -3% | -708% | |||